PERJETA-HERCEPTIN
PERJETA-HERCEPTIN
Approved
DIN Number
02405024
Drug Class
Human
Market Date
May 9, 2013
Company
HC
Hoffmann-La Roche Limited
Product Information
Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.
Product Details
Health Canada regulatory and product classification information
Regulatory Identifiers
DIN Number02405024
AIG Number0254251001
Classification & Schedule
C
Drug Class
Human
S
Schedule
Schedule D
,
Prescription
A
ATC Code
L01FY01 PERTUZUMAB AND TRASTUZUMAB
Product Specifications
Dosage FormKit
,
Solution
,
Powder For Solution
Route of AdministrationIntravenous
AHFS Classification10:00.00
Health Canada Classification
ACTIVE INGREDIENTS (2)
PERTUZUMABActive
Strength: 420 MG / 14 ML
Monograph: PERTUZUMAB
TRASTUZUMABActive
Strength: 440 MG / VIAL
Monograph: TRASTUZUMAB